Matthew Pauls, Director: Pelthos Therapeutics PTHS Sell · Filed 04/06

Trade details

Type: Insider sale
Amount: $8,515.8
Shares · price: 415 sh · $20.52 a share
Held after: 15,521 sh
Stock: Pelthos Therapeutics PTHS
Person: Matthew PaulsDirector
Trade date: 26/04/02
Filed: 26/04/06
Days to filing: 4 days

Sold 2.6% of holdings

Share of holding sold: 2.6%

Pelthos Therapeutics trades, last 26 weeks

What else happened in Pelthos Therapeutics around then

Filed or reported within 30 days of the trade day · 03/03~05/02

Matthew Pauls's recent trades

Matthew PaulsDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$7,925
371 sh
$7,925
Filed 04/06
Traded 04/02
Matthew PaulsDirector
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$424.8K
5,937 sh
$424.8K
Filed 25/03/31
Traded 25/03/28
Matthew PaulsCEO
SellSavara
Sell
Savara
SVRA
$181.1K
54,702 sh
$181.1K
Filed 24/12/16
Traded 24/12/16
Matthew PaulsCEO
SellSavara
Sell
Savara
SVRA
$395.6K
84,000 sh
$395.6K
Filed 23/12/29
Traded 23/12/28

Matthew Pauls, Director — sold $8,516 of Pelthos Therapeutics PTHS · 2.6% of holdings · 10b5-1 plan | Whalegun